DUBLIN--(BUSINESS WIRE)--The "New
Zealand Medical Imaging Services Market by Scans and Application -
Opportunity Analysis and Industry Forecast, 2017-2023" report
has been added to ResearchAndMarkets.com's offering.
The New Zealand medical imaging services market is expected to reach $668 million by 2023, registering a CAGR of 6.7% from 2017 to 2023.
The area of medical imaging comprises various modalities to capture images of the human body for diagnosis and treatment of multiple diseases. Thus, this process plays a vital role in improving public health, evolving from bedside monitoring to high-end digital scanning. Rapid growth in geriatric population is expected to provide an impetus for technological innovations in the imaging industry.
The New Zealand medical imaging services market is driven by increase in prevalence of chronic diseases in New Zealand. In addition, surge in technological advancements in medical imaging and the trend of early diagnosis among people contribute to this growth. However, the high cost associated with the use of sophisticated imaging modalities is expected to hamper the growth. Moreover, high requirement for multiple medical imaging modalities for early diagnosis of diseases provides a major opportunity for key market players in the country.
- Abbott Laboratories
- GE Healthcare
- Philips Healthcare
- Hitachi Medical Corporation
- Hologic, Inc.
- Siemens Healthcare
- Samsung Medison
- Shimadzu Corporation
- Toshiba Medical Systems Corporation
- Esaote S.P.A
- Fujifilm Corporation
Key Topics Covered:
2. Executive Summary
3. Market Overview
4. New Zealand Medical Imaging Services Market, By Scans
5. New Zealand Medical Imaging Services Market, By Application
6. New Zealand Medical Imaging Services Market, By City
7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/wj6bjp/new_zealand?w=4